Communication Skills Training for Lung Cancer Care
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve communication between lung cancer patients and their healthcare providers. It includes a 2-hour training session focused on empathic communication for doctors and clinicians. Patients will complete a short survey about their communication experience with their doctor both before and after these training sessions. Individuals with a confirmed lung cancer diagnosis or a suspicious lung mass who are current or former smokers may be suitable candidates for this study. As an unphased trial, this study offers patients the opportunity to enhance communication with healthcare providers, potentially improving their overall care experience.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on communication between patients and clinicians, so it's unlikely that medication changes are required.
What prior data suggests that this communication skills training is safe for lung cancer patients and clinicians?
Research has shown that training in empathic communication skills is generally safe for participants. Studies on this training have reported no harmful side effects. The training enhances communication between healthcare providers and patients, potentially leading to better care. Participants typically find the training acceptable and manageable. This suggests that the training is a safe option for those considering joining a trial focused on developing these communication skills.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on enhancing clinician-patient communication in lung cancer care through empathic communication skills training. Unlike traditional treatments that focus solely on medical interventions, this approach emphasizes improving the quality of interactions between clinicians and patients. By training clinicians to communicate with empathy, the trial aims to enhance patient satisfaction, understanding, and potentially even treatment outcomes. This innovative approach could lead to a more holistic cancer care experience, addressing emotional and psychological needs alongside physical treatment.
What evidence suggests that this empathic communication skills training is effective for improving communication between lung cancer patients and clinicians?
Research shows that training doctors in empathic communication can enhance their interactions with lung cancer patients. In this trial, thoracic and pulmonary clinicians will undergo a 2-hour empathic communication skills training. Studies have found that this training increases doctors' use of empathy, helping patients feel more understood and supported. Specifically, one study found that doctors who completed this training demonstrated greater empathy during patient visits. Another study suggests that patients might experience less stigma about their lung cancer when doctors communicate with empathy. Overall, this training aims to improve the quality of doctor-patient interactions, potentially leading to better patient outcomes.13678
Who Is on the Research Team?
Jamie Ostroff, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training and Assessment
Clinicians participate in a 2-hour training on empathic communication with lung cancer patients, followed by assessments with standardized patients.
Patient-Clinician Interaction
Audio-recorded consultations between patients and clinicians, and completion of patient questionnaires.
Follow-up
Participants are monitored for outcomes related to communication quality and patient perceptions.
What Are the Treatments Tested in This Trial?
Interventions
- 2-hour empathic communication skills training
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Following informed consent, clinicians will be scheduled to participate in a 2 hour training on empathic communication with lung cancer patients. Surveys will be collected from 6 patients (3 pre-training, 3 post-training). Clinicians will complete one standardized patient assessment before training (pre-SPA) and one assessment after training (post-SPA). These are 12-minute video-recorded clinic consultations with standardized patients (trained actors).
Following informed consent, the patient will complete the patient questionnaire, either electronically, by phone, or on paper. Patients who prefer to complete the survey electronically will be emailed a link to access to a secure electronic (web-based) version of the study assessment which they will have access to from any computer. Completing the survey will take about 15 minutes.
Will have 5 visits/consultations with their patients audio recorded.
Following informed consent, the patient will complete the patient questionnaire, either electronically, by phone, or on paper. Patients who prefer to complete the survey electronically will be emailed a link to access to a secure electronic (web-based) version of the study assessment which they will have access to from any computer. We will include an introductory email with the survey link. Will audio-record actual patient-physician clinical consultations with lung cancer patients at Memorial Sloan Kettering (MSK). Completing the survey will take about 15 minutes. Answer a few open-ended questions about the consultation with the doctor. We will audio record your answers to these questions. This will take about 15 minutes.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Hamad Medical Corporation
Industry Sponsor
Dr. Khalid Mohammed Al Jalham
Hamad Medical Corporation
Chief Executive Officer since 2023
MD
Dr. Khalid Mohammed Al Jalham
Hamad Medical Corporation
Chief Medical Officer
MD
University of Arizona
Collaborator
Weill Medical College of Cornell University
Collaborator
University of Florida
Collaborator
Citations
Empathic communication skills training to reduce lung cancer ...
This paper describes the study protocol for a cluster randomized trial comparing Usual Care (waitlist control group) with Empathic Communication Skills (ECS) ...
EMPATHIC COMMUNICATIONS SKILLS TRAINING
Can we target empathic communication as a way to reduce levels of experienced lung cancer stigma? Develop, evaluate and disseminate ECS Training for oncology.
MA22.11 An Empathic Communication Skills Training ...
Overall, results indicate that the new empathic communication skills training module was well received by thoracic oncology care clinicians and demonstrated ...
Empathic communication skills training to reduce lung ...
The goal of this trial is to investigate the effect of the ECS training on (a) OCP primary outcomes (communication and empathic skill uptake) and secondary ...
Randomized controlled trial to reduce lung cancer stigma ...
Statistical analysis will evaluate the effect of ECS training on primary OCP outcomes (e.g., empathic skill uptake) and secondary patient- ...
6.
trialx.com
trialx.com/clinical-trials/listings/282666/empathic-communication-skills-ecs-training/?&radius=50Empathic Communication Skills (ECS) Training
WLC on patients' reported primary outcomes (lung cancer stigma), and secondary outcomes (perceived clinician empathy, satisfaction with ...
Empathic Communication Skills Training to Reduce Lung ...
The goal of this trial is to investigate the effect of the ECS training on (a) OCP primary outcomes (communication and empathic skill uptake) and secondary ...
Grant - Funding History - National Cancer Institute
Feasibility, acceptability, and initial efficacy of empathic communication skills training to reduce lung cancer stigma in Nigeria: a pilot study. Authors ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.